Q1 2019 Blueprint Medicines Corp Earnings Call Transcript
Good morning, and welcome to the Blueprint Medicines First Quarter 2019 Financial and Operating Results Conference Call. My name is Carla and I'll be your conference operator today. (Operator Instructions) And I would like to turn the call over to Kristin Hodous of Blueprint Medicines.
Thank you, operator. Good morning. This is Kristin Hodous of Blueprint Medicines, and welcome to Blueprint Medicines First Quarter 2019 Financial and Operating Results Conference Call. This morning, we issued a press release, which outlines the topics we plan to discuss today. You can access the press release as well as the slides that we'll be reviewing today by going to the Investors section of our website at www.blueprintmedicines.com.
Today, on our call, Jeff Albers, our Chief Executive Officer, will discuss Blueprint Medicines' first quarter 2019 business highlights; Christy Rossi, our Chief Commercial Officer, will
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |